- AU$106.61m
- AU$101.16m
- AU$3.90m
- 59
- 11
- 77
- 49
Annual balance sheet for Pharmaust, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 2.09 | 2.88 | 3.02 | 2.42 | 2.71 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.259 | 0.298 | 0.242 | 0.185 | 0.148 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 3.02 | 4.07 | 4.36 | 3.73 | 3.02 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.47 | 3.57 | 3.45 | 3.24 | 0.002 |
| Net Intangible Assets | |||||
| Total Assets | 8.6 | 10.7 | 11 | 10.1 | 6.13 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.922 | 1.06 | 0.911 | 1.17 | 1.35 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1.14 | 2.22 | 2.07 | 2.23 | 2.24 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 7.46 | 8.53 | 8.88 | 7.84 | 3.89 |
| Total Liabilities & Shareholders' Equity | 8.6 | 10.7 | 11 | 10.1 | 6.13 |
| Total Common Shares Outstanding |